Work

Utilization and patient characteristics for the trastuzumab originator, biosimilars, and other HER2 inhibitors in the United States.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.39.28_suppl.308

Authors: Young Hee Nam, Aaron Mendelsohn, James Marshall, Nancy Lin, Jeffrey Brown, Cara McDermott, Pamala A. Pawloski, Catherine Lockhart

Institutions: Harvard University, Harvard Pilgrim Health Care, HealthPartners

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3201232883

Cites:

Cited by:

Related to: 10